Shozo Mori

893 total citations
63 papers, 688 citations indexed

About

Shozo Mori is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, Shozo Mori has authored 63 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 24 papers in Surgery and 23 papers in Hepatology. Recurrent topics in Shozo Mori's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Pancreatic and Hepatic Oncology Research (16 papers) and Liver Disease Diagnosis and Treatment (10 papers). Shozo Mori is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Pancreatic and Hepatic Oncology Research (16 papers) and Liver Disease Diagnosis and Treatment (10 papers). Shozo Mori collaborates with scholars based in Japan, South Korea and United States. Shozo Mori's co-authors include H. Satoh, M Shiota, Jiro Fujimoto, Tadashi Yamamoto, Keiichi Kubota, Taku Aoki, Takayuki Shiraki, Masaru Nakano, Ryo Ichinohasama and Masafumi Abe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Shozo Mori

57 papers receiving 665 citations

Peers

Shozo Mori
Bin Meng China
Maria Scardoni Italy
Kathrin Katenkamp Germany
C.J.A. Punt Netherlands
Myung Hee Chang South Korea
Daniel Rauch Switzerland
Yong-Wen Song China
Monika Vyas United States
H Weinstein United States
Masao Hori Japan
Bin Meng China
Shozo Mori
Citations per year, relative to Shozo Mori Shozo Mori (= 1×) peers Bin Meng

Countries citing papers authored by Shozo Mori

Since Specialization
Citations

This map shows the geographic impact of Shozo Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shozo Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shozo Mori more than expected).

Fields of papers citing papers by Shozo Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shozo Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shozo Mori. The network helps show where Shozo Mori may publish in the future.

Co-authorship network of co-authors of Shozo Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Shozo Mori. A scholar is included among the top collaborators of Shozo Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shozo Mori. Shozo Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shiraki, Takayuki, Takayuki Shimizu, Kyung Hwa Park, et al.. (2024). Proposal of an integrated staging system using albumin-bilirubin grade and serum alpha-fetoprotein values for predicting postoperative prognosis of recurrent hepatocellular carcinoma. European Journal of Surgical Oncology. 50(6). 108356–108356. 1 indexed citations
2.
Aoki, Taku, Shozo Mori, & Keiichi Kubota. (2024). Neoadjuvant and Adjuvant Chemotherapy for Pancreatic Adenocarcinoma: Literature Review and Our Experience of NAC-GS. Cancers. 16(5). 910–910. 3 indexed citations
3.
Mori, Shozo, Taku Aoki, Takayuki Shimizu, et al.. (2021). Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma. Cancer Chemotherapy and Pharmacology. 88(1). 109–120. 2 indexed citations
4.
Mori, Shozo, Taku Aoki, Takayuki Shimizu, et al.. (2021). Efficacy of Adjuvant Chemotherapy According to the Pathological Response to Neoadjuvant Chemotherapy Among Patients With Pancreatic Ductal Adenocarcinoma. Anticancer Research. 41(3). 1629–1639. 5 indexed citations
5.
Mori, Shozo, Taku Aoki, Takayuki Shiraki, et al.. (2021). Efficacy and Feasibility of Adjuvant Gemcitabine Plus Cisplatin Chemotherapy After Major Hepatectomy for Biliary Tract Cancer. Anticancer Research. 41(10). 5231–5240.
6.
Shimizu, Takayuki, Mitsuru Ishizuka, Takayuki Shiraki, et al.. (2020). The clinical influence of the preoperative lymphocyte‐to‐monocyte ratio on the postoperative outcome of patients with early‐stage gastrointestinal cancer. Annals of Gastroenterological Surgery. 4(5). 580–590. 5 indexed citations
7.
Kubota, Keiichi, Takayuki Shimizu, Kyung Hwa Park, et al.. (2020). Features of Hepatocellular Carcinoma With Micro Hepatic Vein Invasion and their Correlation With Hepatitis B and C Virus. Anticancer Research. 40(7). 3983–3990. 1 indexed citations
8.
Shimizu, Takayuki, Mitsuru Ishizuka, Kyung Hwa Park, et al.. (2019). Preoperative lymphocyte‐to‐monocyte ratio is useful for stratifying the prognosis of hepatocellular carcinoma patients with a low Cancer of the Liver Italian Program score undergoing curative resection. Annals of Gastroenterological Surgery. 3(3). 325–335. 11 indexed citations
9.
Shimizu, Takayuki, Keiichi Kubota, Takayuki Shiraki, et al.. (2019). A technique for taping inferior vena cava caudal to the duodenum: duodenal penetration by IVC filter strut after retroperitoneal lymph node dissection—usefulness of the mesenteric approach. SHILAP Revista de lepidopterología. 5(1). 69–69. 1 indexed citations
10.
Shimizu, Takayuki, Taku Aoki, Shozo Mori, et al.. (2018). Tumor DNA-dependent protein kinase catalytic subunit expression is associated with hepatitis B surface antigen status and tumor progression in patients with hepatocellular carcinoma. Scientific Reports. 8(1). 15019–15019. 3 indexed citations
11.
Shimoda, Mitsugi, Takayuki Shiraki, Shozo Mori, et al.. (2016). Risk Factors for Early Recurrence of Single Lesion Hepatocellular Carcinoma After Curative Resection. World Journal of Surgery. 40(10). 2466–2471. 45 indexed citations
12.
Kim, Ho, Kyung‐Suk Suh, YoungRok Choi, et al.. (2012). Partial Splenic Artery Embolization for Thrombocytopenia and Uncontrolled Massive Ascites After Liver Transplantation. Transplantation Proceedings. 44(3). 755–756. 18 indexed citations
13.
Shineha, Ryuzaburo, Kenichi Yokota, Katsu Hirayama, et al.. (1994). Control of the Excessive Reaction after Surgery for Esophageal Carcinoma with Preoperative Administration of the Cortico-steroids.. The Japanese Journal of Gastroenterological Surgery. 27(4). 841–848. 11 indexed citations
14.
Kitamura, Michihiko, T Nishihira, Takashi Akaishi, et al.. (1989). Mucosal changes of trachea and bronchi after resection for carcinoma of the thoracic esophagus.. The Japanese Journal of Gastroenterological Surgery. 22(8). 1966–1969. 1 indexed citations
15.
Kitamura, Michihiko, T Nishihira, Katsu Hirayama, et al.. (1987). Pulmonary complications after operation for carcinoma of the thoracic esophagus. Analysis of the cases during past 10 years.. The Japanese Journal of Gastroenterological Surgery. 20(12). 2706–2711. 2 indexed citations
16.
Watanabe, Masatoshi, et al.. (1986). . The Japanese Journal of Gastroenterological Surgery. 19(10). 2142–2145. 2 indexed citations
17.
18.
Mori, Shozo, et al.. (1984). . The Japanese Journal of Gastroenterological Surgery. 17(8). 1599–1602. 1 indexed citations
19.
Sasaki, Junichi, et al.. (1981). FIVE CASES OF THE INTESTINAL OBSTRUCTION BY RADIATION INJURY. The Japanese Journal of Gastroenterological Surgery. 14(1). 117–122. 1 indexed citations
20.
Mori, Shozo, et al.. (1976). SPONTANEOUS RUPTURE OF THE ESOPHAGUS REVIEW OF 59 CASES IN JAPAN. The Japanese Journal of Gastroenterological Surgery. 9(2). 91–102.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin Meng Breakdown of academic impact, for papers by Maria Scardoni Breakdown of academic impact, for papers by Kathrin Katenkamp Breakdown of academic impact, for papers by C.J.A. Punt Breakdown of academic impact, for papers by Myung Hee Chang Breakdown of academic impact, for papers by Daniel Rauch Breakdown of academic impact, for papers by Yong-Wen Song Breakdown of academic impact, for papers by Monika Vyas Breakdown of academic impact, for papers by H Weinstein Breakdown of academic impact, for papers by Masao Hori
Rankless by CCL
2026